Daniel Barrell

Biochemistry, Genetics and Molecular Biology · Life Sciences

30h-index30.8kcitations60works13.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genomics and Phylogenetic Studies(20), Bioinformatics and Genomic Networks(18), Biomedical Text Mining and Ontologies(18), PARP inhibition in cancer therapy(12), Health Systems, Economic Evaluations, Quality of Life(8)

Publications59 total

Abstract 3007: The epigenetic regulators KDM5C and KAT6A influence AKT inhibitor response in ER positive breast cancer
Cancer Research·2025
Genome-wide CRISPR screens identify the YAP/TEAD axis as a driver of persister cells in EGFR mutant lung cancer
Communications Biology·2024· 26 citedOpen Access
A Multi-Modal Analysis of Acquired Resistance to Acalabrutinib and Pirtobrutinib Provides Potential Strategies to Augment Treatment Outcome with BTKi Drugs
Blood·2023Open Access
Supplementary Table S2 from Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition
2023Open Access
Data from Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition
2023Open Access
Data from Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition
2023Open Access
Supplementary Table S3 from Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition
2023Open Access
Supplementary Table S1 from Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition
2023Open Access
Supplementary Table S2 from Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition
2023Open Access
Supplementary Figures S1-S5 from Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition
2023Open Access
Supplementary Table S3 from Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition
2023Open Access
Supplementary Table S1 from Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition
2023Open Access
Supplementary Figures S1-S5 from Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition
2023Open Access
Hydroxymethylation profile of cell-free DNA is a biomarker for early colorectal cancer
Scientific Reports·2022· 25 citedOpen Access
Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition
Cancer Research Communications·2022· 24 citedOpen Access
Drug-gene interaction screens coupled to tumour data analyses identify the most clinically-relevant cancer vulnerabilities driving sensitivity to PARP inhibition
2022· 5 citedOpen Access
Author Correction: Expanded encyclopaedias of DNA elements in the human and mouse genomes
Nature·2022· 21 citedOpen Access
Author Correction: Perspectives on ENCODE
Nature·2022Open Access
Hydroxymethylation profile of cell free DNA is a biomarker for early colorectal cancer
2021· 1 citedOpen Access
Perspectives on ENCODE
Nature·2020· 214 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Bronwen Aken(20), Rolf Apweiler(17), Emily Dimmer(15), Stephen M. J. Searle(12), Evelyn Camon(10), David Binns(10), Miika Ahdesmäki(10), Amonida Zadissa(9), Thibaut Hourlier(9), Magali Ruffier(9), Paul Flicek(9), Rachael P. Huntley(9), Jennifer Harrow(8), Stephen J. Trevanion(8), Tim Hubbard(7), M Ridwan Amode(7), Carlos García Girón(7), Leo I. Gordon(7), William McLaren(7), Anne Parker(7)